Date Filed | Type | Description |
10/05/2023 |
SC 13D/A
| D. E. SHAW & CO, L.P. reports a 5.7% stake in Diversified Healthcare Trust |
09/26/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/21/2023 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
08/14/2023 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
08/08/2023 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
08/07/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/07/2023 |
PX14A6G
| Form PX14A6G - Notice of exempt solicitation submitted by non-management: |
08/07/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/03/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/03/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/02/2023 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
08/02/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/02/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/01/2023 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/01/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/01/2023 |
8-K
| Quarterly results |
07/31/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/31/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/28/2023 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
07/27/2023 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
07/27/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/21/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/21/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/21/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/21/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/21/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/21/2023 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
07/19/2023 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
07/18/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/14/2023 |
PX14A6G
| Form PX14A6G - Notice of exempt solicitation submitted by non-management: |
07/05/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
06/30/2023 |
SC 13D
| H/2 Special Opportunities IV L.P. reports a 6.2% stake in DIVERSIFIED HEALTHCARE TRUST |
06/29/2023 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
|